The acquisition of CrossRoads, which delivers a range of procedure-specific and sterile-packed implants and instrumentation systems for lower extremity indications, is part of DePuy Synthes' commitment to drive its orthopaedic, podiatric and medtech advancements through both internal and external innovation
Johnson & Johnson headquarters in New Brunswick, New Jersey. (Credit: Ekem/Wikipedia )
DePuy Synthes, the orthopaedics company of Johnson & Johnson, has acquired US-based foot and ankle company CrossRoads Extremity Systems for an undisclosed sum.
Based in Tennessee, CrossRoads offers a range of procedure-specific, sterile-packed implants and instrumentation systems for lower extremity indications.
Private equity company HealthpointCapital, which was the majority investor in CrossRoads, had worked with the company to develop it into a growth leader in foot and ankle segment.
The acquisition is part of DePuy Synthes’ commitment to drive its orthopaedic, podiatric and medtech advancements through both internal and external innovation.
DePuy Synthes trauma, extremities, craniomaxillofacial and animal health worldwide president Oray Boston said: “At DePuy Synthes, we look at innovation with one goal in mind: to bring differentiated solutions to market to address the unmet needs of surgeons and patients around the world.
“Healthy feet are a foundational element of overall good health, and we are thrilled about the acquisition of CrossRoads and the opportunity to accelerate meaningful innovation by strengthening our offering for elective foot and ankle procedures, enabling us to provide more comprehensive and leading-edge options to surgeons and patients.”
CrossRoads product portfolio consists of miniBunion3D, dynaBunion 4D and DynaForce staple compression plates.
The miniBunion system is a minimally invasive solution for metatarsal bone osteotomy, a procedure to manage mild to moderate hallux valgus. The system helps to minimise the incision size compared against traditional techniques.
The dynaBunion lapidus system serves as an option for lapidus bunionectomy, a procedure to manage moderate to severe hallux valgus.
It offers instrumentation and implants for the correction of bunions in four dimensions through smaller incisions.
DynaForce staple compression plates integrate stability with dynamic continuous compression at the fusion site. All the systems serve as surgical options to deal with various bunion deformities ranging from mild to severe.
CrossRoads also provides EcoSMART instrument service, which delivers sterilised and reusable instruments for surgical cases, as well as post-surgery instrument recovery and processing to minimise waste and inefficiencies in the operating room.
In December 2019, Johnson & Johnson announced the acquisition of the remaining stake in Verb Surgical, a joint venture company with Verily, an Alphabet company.